AbbVie is now facing six antitrust class-action lawsuits which claim that the company illegally stopped competition for its arthritis treatment Humira.
The European Patent Office has issued a new CRISPR/Cas9 patent to inventor Emmanuelle Charpentier, one of the key figures in the CRISPR landscape.
The English High Court will hear a patent dispute between a subsidiary of biopharmaceutical company Sanofi and British-Dutch consumer goods brand Unilever.
European Patent Office president António Campinos will refer a recent decision on the patentability of exclusively obtained by essentially biological processes to the office’s Enlarged Board of Appeal.
Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.
Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.
A “biotech boom” is underway in the UK, according to a new report from UK investment management firm Downing.
A California-based company which breeds berries has filed a patent infringement claim against a competitor.
The US Court of Appeals for the Federal Circuit has warned against implementing “too broad” an interpretation of the Alice test as it ruled that “treatment claims” were eligible for patenting.
Activist group No Patents on Seeds has filed an opposition against a patent on lettuce, owned by Dutch food supplier Rijk Zwaan Zaadteelt.